PRIMARY healthcare professionals now have free access to peer-reviewed, accredited online education on key respiratory topics like breathlessness, COPD, and asthma.
Funded by the Australian Government, the Quality use of Medicines in Chronic Airways Disease (QUAD) program is delivered by the Lung Learning Partnership of Lung Foundation Australia, The Thoracic Society of Australia and New Zealand, and Asthma Australia.
Lung Foundation Australia CEO Mark Brooke described the QUAD program as a "game changer", providing easy access to best-practice, evidence-based education.
The first package on breathlessness, accredited by the Royal Australian College of General Practitioners, is now available to health professionals.
Asthma and COPD modules will launch in late 2024.
Asthma Australia Director of Health Knowledge and Translation, Anthony Flynn, said the program and the three education packages were informed by a consultative design process, with healthcare professionals and people with lived experience.
"It will deliver useful and relevant content meeting the contemporary needs of healthcare professionals as they support people with chronic airways disease," said Flynn.
Pre-registration is open, and the QUAD modules can be accessed via the Lung Learning Hub, HERE. JG
The above article was sent to subscribers in Pharmacy Daily's issue from 10 Sep 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Sep 24
